Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (362)
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,144
Price
$119.71
Total Value
$615.79K
Shares Held After
559,524
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,915
Price
$110.30
Total Value
$211.22K
Shares Held After
3,316,924
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
337
Price
$129.61
Total Value
$43.68K
Shares Held After
2,862,351
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
14,351
Price
$108.83
Total Value
$1.56M
Shares Held After
3,318,839
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
2,197
Price
$128.69
Total Value
$282.73K
Shares Held After
2,862,688
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
159
Price
$108.02
Total Value
$17.18K
Shares Held After
3,333,190
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
25,075
Price
$127.37
Total Value
$3.19M
Shares Held After
2,864,885
% of Holdings
0.9%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
9,994
Price
$107.30
Total Value
$1.07M
Shares Held After
3,333,349
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
1,609
Price
$126.71
Total Value
$203.88K
Shares Held After
2,889,960
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
3,716
Price
$125.82
Total Value
$467.55K
Shares Held After
2,891,569
% of Holdings
0.1%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
11,711
Price
$124.61
Total Value
$1.46M
Shares Held After
2,895,285
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,860
Price
$123.62
Total Value
$1.34M
Shares Held After
2,906,996
% of Holdings
0.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
4,977
Price
$122.67
Total Value
$610.53K
Shares Held After
2,917,856
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
40,774
Price
$121.38
Total Value
$4.95M
Shares Held After
2,922,833
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
112,299
Price
$120.66
Total Value
$13.55M
Shares Held After
2,963,607
% of Holdings
3.7%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
37,179
Price
$119.71
Total Value
$4.45M
Shares Held After
3,075,906
% of Holdings
1.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
5,394
Price
$20.00
Total Value
$107.88K
Shares Held After
115,005
% of Holdings
4.5%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
28,935
Price
$20.06
Total Value
$580.51K
Shares Held After
13,579
% of Holdings
68.1%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$119.00
Total Value
$297.50K
Shares Held After
50,195
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$109.00
Total Value
$272.50K
Shares Held After
52,695
% of Holdings
4.5%
Showing 251–300 of 362 transactions (page 6 of 8)